In this activity, Dr. Bronté-Hall discusses the care and management of adult patients with sickle cell disease. This activity will conclude with a review of the Florida-based quality improvement study, designed to improve quality of care for patients, and how to implement and monitor the standard of care. Don't miss the opportunity to participate in this QI program led by Dr. Bronté-Hall. Information on how you can participate will be provided at the end of the program.

In this activity, two experts discuss the care of pediatric patients with sickle cell disease, including updated information on therapies. This activity will conclude with a review of the Florida-based quality improvement study, designed to improve quality of care for patients, and how to implement and monitor the standard of care. Don't miss the opportunity to participate in this QI program led by Dr. Bronté-Hall. Information on how you can participate will be provided at the end of the program. ​

The impact of COVID-19 on the routine management of patients with sickle cell disease (SCD) has been substantial and complex, as clinicians now need to ensure that patients receive appropriate care for SCD in balance with the challenges posed by the pandemic. In this article, Lanetta Bronté-Hall, MD, MPH, MSPH discusses the current data regarding the prevalence of COVID-19 among patients with SCD and provides guidance on best practice on the treatment and monitoring of SCD during the COVID-19 pandemic.